5-yr-white-trans
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE pCPA Assessment
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • RWE/Innovative Agreements
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Drugs for Rare Diseases Sub-Report
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US
logo-top-c-r
5-yr-white-trans
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE pCPA Assessment
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • RWE/Innovative Agreements
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Drugs for Rare Diseases Sub-Report
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US

MORSE Consulting Releases its Third Annual pCPA Year in Review Infographic (2019 Edition)

February 5, 2020
-
Market Access News, Publications
-
Posted by MORSE - < 1 min read.

MORSE Consulting is pleased to release our Third Annual pCPA Year in Review infographic – 2019 Edition.  This resource is aimed at helping market access stakeholders understand the top-line pCPA highlights from 2019.

This infographic compares year-over-year metrics including:

  • pCPA activity summary;
  • average time to complete a negotiation;
  • files adjudicated by the pCPA; and
  • average negotiation duration by source.

This infographic is an excerpt from the 2019 update of MORSE Consulting’s Canadian Reimbursement Trends and Timelines (CRTT) report. For more information on this comprehensive public reimbursement timelines report, please click here.

 

Click on graphic to print or see full-size

 

Please contact info@morseconsulting.ca regarding any questions on this infographic or on the CRTT report.

Embed this infographic (cut and paste code) on your website with attribution:

 

 

To receive updates similar to this one please be sure to sign up for MORSE Signals, our free e-mail newsletter service.

Share
Tags
CDR
Market Access
Pan Canadian Pharmaceutical Alliance
pCODR
pCPA
pCPAO
Reimbursement
← PREVIOUS POST
pCPA Closing in on 300 Completed Negotiations
NEXT POST →
A Busy 2019 ends with a quiet December

Contact Us
MORSE Consulting Inc.
Toronto | Ottawa, Canada
+1-647-717-3179 (Toronto)
+1-613-864-8645 (Ottawa)
info@morseconsulting.ca
Social
Connect & Follow:

New Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2022 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
MORSE Consulting Releases its Third Annual pCPA Year in Review Infographic (2019 Edition)